Author:
Prescot Andrew P.,Prisciandaro James J.,Miller Steven R.,Ingenito Gary,Kondo Douglas G.,Renshaw Perry F.
Funder
Catalyst Pharmaceuticals Inc
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Pouwels, P. J. & Frahm, J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39, 53–60 (1998).
2. Mason, G. F. & Krystal, J. H. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. NMR Biomed 19, 690–701 (2006).
3. Draper, A. et al. Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome. Curr Biol 24, 2343–2347 (2014).
4. Petroff, O. A., Behar, K. L. & Rothman, D. L. New NMR measurements in epilepsy. Measuring brain GABA in patients with complex partial seizures. Adv Neurol 79, 939–945 (1999).
5. Petroff, O. A., Rothman, D. L., Behar, K. L. & Mattson, R. H. Low brain GABA level is associated with poor seizure control. Ann Neurol 40, 908–911 (1996).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献